VEGF regulates cell behavior during vasculogenesis

Developmental Biology

Volumn 224, Issue 2, 2000, Pages 178-188

  Drake, Christopher J ^a   LaRue, Amanda ^a   Ferrara, Napoleone ^b   Little, Charles D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b GENENTECH INC   (United States)

Author keywords

Angioblasts morphogenesis; Vasculogenesis; VEGF

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; MORPHOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALIA; AVES;

EID: 0034663072     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.2000.9744     Document Type: Article

References (32)

1. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
2. Requirement of vascular integrin alpha v beta 3 for angiogenesis
3. Antiomorphology of the human renal clear cell carcinoma. A light and scanning electron microscopic study
4. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
5. Embryonic vascular development: Immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos
6. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
7. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
8. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis
9. An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularization
10. Antibodies to beta 1 integrins cause alterations of aortic vasculogenesis, in vivo
11. Vasculogenesis in the day 6.5 to 9.5 mouse embryo
12. Morphogenesis of the first blood vessels
13. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization
14. The morphogenesis of primordial vascular networks
15. VEGF and vascular fusion: Implications for normal and pathological vessels
16. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
17. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
18. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
19. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
20. Definition of two angiogenic pathways by distinct alpha v integrins
21. VEGF is required for growth and survival of neonatal mice
22. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
23. Evidence for characteristic vascular patterns in solid tumours: Quantitative studies using corrosion casts
24. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
25. High affinity VEGF binding and developmental expression suggest FLK-1 as a major regulator of vasculogenesis and angiogenesis
26. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
27. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the avb3 integrin, osteopontin, and thrombin
28. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis
29. Failure of blood-island and vasculogenesis in Flk-1-deficient mice
30. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
31. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
32. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D